Korro Bio KRRO
NASDAQ KRRO
$9.91 +0.35 (+3.66%)
At close: Sep 30, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Receivables (2024 - 2025)

Updated

Korro Bio (KRRO) recorded Receivables of $969,000 in Q4 2025, down 42.9% from $1.7 million a year earlier but up 18.2% from the prior quarter.

Analysis

Korro Bio (KRRO) Receivables (2024 - 2025) Analysis & Trends

Starting with Q3 2024, Korro Bio's Receivables history includes 6 quarters.

  • Across earlier years, Receivables came in at $1.7 million in FY2024.
  • Quarterly Receivables has ranged from $820,000 in Q3 2025 to $10 million in Q3 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $820,000 (Q3 2025), $1.09 million (Q2 2025) and $1.92 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 19.05 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 13.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.68 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 5.06 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.13 Bn
10 Korro Bio 145.73 Mn -250.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 969,000.00
Sep 30, 2025 820,000.00
Jun 30, 2025 1.09 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 1.70 Mn
Sep 30, 2024 10.00 Mn
API Access

Korro Bio Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=KRRO&period=max&api_key=YOUR_API_KEY